Daiwa Securities Group Inc. Buys 24,588 Shares of American Healthcare REIT, Inc. $AHR

Daiwa Securities Group Inc. raised its stake in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 5.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 443,678 shares of the company’s stock after purchasing an additional 24,588 shares during the period. Daiwa Securities Group Inc.’s holdings in American Healthcare REIT were worth $20,879,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. Thames Capital Management LLC acquired a new stake in American Healthcare REIT during the 4th quarter worth $4,042,000. Allianz Asset Management GmbH boosted its stake in American Healthcare REIT by 188.7% during the 3rd quarter. Allianz Asset Management GmbH now owns 261,188 shares of the company’s stock worth $10,973,000 after purchasing an additional 170,709 shares during the last quarter. Greenland Capital Management LP boosted its stake in American Healthcare REIT by 85.2% during the 3rd quarter. Greenland Capital Management LP now owns 91,000 shares of the company’s stock worth $3,823,000 after purchasing an additional 41,876 shares during the last quarter. American Century Companies Inc. boosted its stake in American Healthcare REIT by 11.1% during the 3rd quarter. American Century Companies Inc. now owns 2,838,692 shares of the company’s stock worth $119,254,000 after purchasing an additional 282,692 shares during the last quarter. Finally, Asset Management One Co. Ltd. boosted its stake in American Healthcare REIT by 16.0% during the 4th quarter. Asset Management One Co. Ltd. now owns 291,426 shares of the company’s stock worth $14,076,000 after purchasing an additional 40,231 shares during the last quarter. Institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Up 2.6%

Shares of AHR opened at $47.56 on Friday. The firm has a market cap of $9.17 billion, a P/E ratio of 82.01, a price-to-earnings-growth ratio of 1.56 and a beta of 0.80. American Healthcare REIT, Inc. has a 12-month low of $34.72 and a 12-month high of $54.67. The company’s 50-day moving average price is $49.25 and its 200 day moving average price is $49.32. The company has a current ratio of 0.45, a quick ratio of 0.45 and a debt-to-equity ratio of 0.28.

American Healthcare REIT (NYSE:AHR) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.13 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.34). The company had revenue of $650.77 million during the quarter, compared to analysts’ expectations of $667.57 million. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.33%. The firm’s quarterly revenue was up 20.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.38 earnings per share. American Healthcare REIT has set its FY 2026 guidance at 2.030-2.090 EPS. On average, sell-side analysts forecast that American Healthcare REIT, Inc. will post 2.06 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 17th. Investors of record on Tuesday, March 31st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.1%. The ex-dividend date was Tuesday, March 31st. American Healthcare REIT’s payout ratio is 172.41%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AHR. Weiss Ratings cut shares of American Healthcare REIT from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday. Truist Financial lifted their target price on shares of American Healthcare REIT from $52.00 to $57.00 and gave the stock a “buy” rating in a research note on Thursday, March 12th. Royal Bank Of Canada lifted their price target on American Healthcare REIT from $54.00 to $56.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. KeyCorp lifted their price target on American Healthcare REIT from $55.00 to $58.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Finally, Scotiabank lifted their price target on American Healthcare REIT from $55.00 to $59.00 and gave the stock a “sector outperform” rating in a report on Wednesday, March 11th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, American Healthcare REIT currently has an average rating of “Moderate Buy” and an average price target of $55.64.

Insider Transactions at American Healthcare REIT

In related news, EVP Mark E. Foster sold 2,000 shares of the business’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $48.32, for a total value of $96,640.00. Following the sale, the executive vice president directly owned 55,495 shares in the company, valued at approximately $2,681,518.40. The trade was a 3.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.75% of the company’s stock.

About American Healthcare REIT

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.